Advertisement
Research ArticleBehavioral Pharmacology

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleBehavioral Pharmacology

Rapidly Acting Antidepressant Actions of LY341495

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement